Bicyclopyrone; Pesticide Tolerances, 86960-86966 [2016-29005]
Download as PDF
86960
Federal Register / Vol. 81, No. 232 / Friday, December 2, 2016 / Rules and Regulations
lower fee, which lessens the economic
impact of these regulations.
Accordingly, a regulatory flexibility
analysis is not required. Pursuant to
section 7805(f) of the Internal Revenue
Code, the notice of proposed rulemaking
was submitted to the Chief Counsel for
Advocacy of the Small Business
Administration for comment on its
impact on small business and no
comments were received.
Drafting Information
The principal author of these
regulations is Maria Del Pilar Austin of
the Office of the Associate Chief
Counsel (Procedure and
Administration). Other personnel from
the Treasury Department and the IRS
participated in their development.
List of Subjects in 26 CFR Part 300
Reporting and recordkeeping
requirements, User fees.
Par. 3. In § 300.2, paragraphs (b) and
(d) are revised to read as follows:
■
Adoption of Amendments to the
Regulations
Accordingly, 26 CFR part 300 is
amended as follows:
§ 300.2 Restructuring or reinstatement of
installment agreement fee.
*
PART 300—USER FEES
Paragraph 1. The authority citation
for part 300 continues to read as
follows:
■
Authority: 31 U.S.C. 9701.
Par. 2. In § 300.1, paragraphs (b) and
(d) are revised to read as follows:
■
§ 300.1
Installment agreement fee.
jstallworth on DSK7TPTVN1PROD with RULES
*
*
*
*
*
(b) Fee. The fee for entering into an
installment agreement before January 1,
2017, is $120. The fee for entering into
an installment agreement on or after
January 1, 2017, is $225. A reduced fee
applies in the following situations:
(1) For installment agreements
entered into before January 1, 2017, the
fee is $52 when the taxpayer pays by
way of a direct debit from the taxpayer’s
bank account. The fee is $107 when the
taxpayer pays by way of a direct debit
from the taxpayer’s bank account for
installment agreements entered into on
or after January 1, 2017;
(2) For online payment agreements
entered into before January 1, 2017, the
fee is $120, except that the fee is $52
when the taxpayer pays by way of a
direct debit from the taxpayer’s bank
account. The fee is $149 for entering
into online payment agreements on or
after January 1, 2017, except that the fee
is $31 when the taxpayer pays by way
of a direct debit from the taxpayer’s
bank account; and
(3) Notwithstanding the type of
installment agreement and method of
VerDate Sep<11>2014
14:49 Dec 01, 2016
Jkt 241001
payment, the fee is $43 if the taxpayer
is a low-income taxpayer, that is, an
individual who falls at or below 250
percent of the dollar criteria established
by the poverty guidelines updated
annually in the Federal Register by the
U.S. Department of Health and Human
Services under authority of section
673(2) of the Omnibus Budget
Reconciliation Act of 1981 (95 Stat. 357,
511), or such other measure that is
adopted by the Secretary, except that
the fee is $31 when the taxpayer pays
by way of a direct debit from the
taxpayer’s bank account with respect to
online payment agreements entered into
on or after January 1, 2017;
*
*
*
*
*
(d) Applicability date. This section is
applicable beginning January 1, 2017.
*
*
*
*
(b) Fee. The fee for restructuring or
reinstating an installment agreement
before January 1, 2017, is $50. The fee
for restructuring or reinstating an
installment agreement on or after
January 1, 2017, is $89. If the taxpayer
is a low-income taxpayer, that is, an
individual who falls at or below 250
percent of the dollar criteria established
by the poverty guidelines updated
annually in the Federal Register by the
U.S. Department of Health and Human
Services under authority of section
673(2) of the Omnibus Budget
Reconciliation Act of 1981 (95 Stat. 357,
511), or such other measure that is
adopted by the Secretary, then the fee
for restructuring or reinstating an
installment agreement on or after
January 1, 2017 is $43.
*
*
*
*
*
(d) Applicability date. This section is
applicable beginning January 1, 2017.
John Dalrymple,
Deputy Commissioner for Services and
Enforcement.
Approved: November 16, 2016.
Mark J. Mazur,
Assistant Secretary of the Treasury (Tax
Policy).
[FR Doc. 2016–28936 Filed 11–29–16; 11:15 am]
BILLING CODE 4830–01–P
PO 00000
Frm 00056
Fmt 4700
Sfmt 4700
ENVIRONMENTAL PROTECTION
AGENCY
40 CFR Part 180
[EPA–HQ–OPP–2015–0560; FRL–9954–63]
Bicyclopyrone; Pesticide Tolerances
Environmental Protection
Agency (EPA).
ACTION: Final rule.
AGENCY:
This regulation establishes
tolerances for residues of bicyclopyrone
in or on wheat and barley. Syngenta
Crop Protection, LLC. requested these
tolerances under the Federal Food,
Drug, and Cosmetic Act (FFDCA).
DATES: This regulation is effective
December 2, 2016. Objections and
requests for hearings must be received
on or before January 31, 2017, and must
be filed in accordance with the
instructions provided in 40 CFR part
178 (see also Unit I.C. of the
SUPPLEMENTARY INFORMATION).
ADDRESSES: The docket for this action,
identified by docket identification (ID)
number EPA–HQ–OPP–2015–0560, is
available at https://www.regulations.gov
or at the Office of Pesticide Programs
Regulatory Public Docket (OPP Docket)
in the Environmental Protection Agency
Docket Center (EPA/DC), West William
Jefferson Clinton Bldg., Rm. 3334, 1301
Constitution Ave. NW., Washington, DC
20460–0001. The Public Reading Room
is open from 8:30 a.m. to 4:30 p.m.,
Monday through Friday, excluding legal
holidays. The telephone number for the
Public Reading Room is (202) 566–1744,
and the telephone number for the OPP
Docket is (703) 305–5805. Please review
the visitor instructions and additional
information about the docket available
at https://www.epa.gov/dockets.
FOR FURTHER INFORMATION CONTACT:
Michael Goodis, Registration Division
(7505P), Office of Pesticide Programs,
Environmental Protection Agency, 1200
Pennsylvania Ave. NW., Washington,
DC 20460–0001; main telephone
number: (703) 305–7090; email address:
RDFRNotices@epa.gov.
SUPPLEMENTARY INFORMATION:
SUMMARY:
I. General Information
A. Does this action apply to me?
You may be potentially affected by
this action if you are an agricultural
producer, food manufacturer, or
pesticide manufacturer. The following
list of North American Industrial
Classification System (NAICS) codes is
not intended to be exhaustive, but rather
provides a guide to help readers
determine whether this document
E:\FR\FM\02DER1.SGM
02DER1
Federal Register / Vol. 81, No. 232 / Friday, December 2, 2016 / Rules and Regulations
applies to them. Potentially affected
entities may include:
• Crop production (NAICS code 111).
• Animal production (NAICS code
112).
• Food manufacturing (NAICS code
311).
• Pesticide manufacturing (NAICS
code 32532).
jstallworth on DSK7TPTVN1PROD with RULES
B. How can I get electronic access to
other related information?
You may access a frequently updated
electronic version of EPA’s tolerance
regulations at 40 CFR part 180 through
the Government Printing Office’s e-CFR
site at https://www.ecfr.gov/cgi-bin/textidx?&c=ecfr&tpl=/ecfrbrowse/Title40/
40tab_02.tpl.
C. How can I file an objection or hearing
request?
Under FFDCA section 408(g), 21
U.S.C. 346a, any person may file an
objection to any aspect of this regulation
and may also request a hearing on those
objections. You must file your objection
or request a hearing on this regulation
in accordance with the instructions
provided in 40 CFR part 178. To ensure
proper receipt by EPA, you must
identify docket ID number EPA–HQ–
OPP–2015–0560 in the subject line on
the first page of your submission. All
objections and requests for a hearing
must be in writing, and must be
received by the Hearing Clerk on or
before January 31, 2017. Addresses for
mail and hand delivery of objections
and hearing requests are provided in 40
CFR 178.25(b).
In addition to filing an objection or
hearing request with the Hearing Clerk
as described in 40 CFR part 178, please
submit a copy of the filing (excluding
any Confidential Business Information
(CBI)) for inclusion in the public docket.
Information not marked confidential
pursuant to 40 CFR part 2 may be
disclosed publicly by EPA without prior
notice. Submit the non-CBI copy of your
objection or hearing request, identified
by docket ID number EPA–HQ–OPP–
2015–0560, by one of the following
methods:
• Federal eRulemaking Portal: https://
www.regulations.gov. Follow the online
instructions for submitting comments.
Do not submit electronically any
information you consider to be CBI or
other information whose disclosure is
restricted by statute.
• Mail: OPP Docket, Environmental
Protection Agency Docket Center (EPA/
DC), (28221T), 1200 Pennsylvania Ave.
NW., Washington, DC 20460–0001.
• Hand Delivery: To make special
arrangements for hand delivery or
delivery of boxed information, please
VerDate Sep<11>2014
14:49 Dec 01, 2016
Jkt 241001
follow the instructions at https://
www.epa.gov/dockets/contacts.html.
Additional instructions on commenting
or visiting the docket, along with more
information about dockets generally, is
available at https://www.epa.gov/
dockets.
II. Summary of Petitioned-For
Tolerance
In the Federal Register of October 21,
2015 (80 FR 63731) (FRL–9935–29),
EPA issued a document pursuant to
FFDCA section 408(d)(3), 21 U.S.C.
346a(d)(3), announcing the filing of a
pesticide petition (PP 5F8374) by
Syngenta Crop Protection, LLC., P.O.
Box 18300, Greensboro, NC 27419. The
petition requested that 40 CFR part
180.682 be amended by establishing
tolerances for residues of the herbicide,
bicyclopyrone: 4-hydroxy-3-{2-[(2methoxyethoxy) methyl}-6(trifluoromethyl)-3-pyridylcarbonyl}
bicyclo oct-3-en-2-one, in or on the raw
agricultural commodities: Barley, bran
at 0.15 parts per million (ppm); barley,
germ at 0.10 ppm; barley, grain, at 0.07
ppm; barley, hay at 0.3 ppm; barley,
straw at 0.50 ppm; wheat, aspirated
grain fractions at 0.50 ppm; wheat, bran
at 0.15 ppm; wheat, forage at 0.50 ppm;
wheat, germ at 0.10 ppm; wheat, grain,
at 0.04 ppm; wheat, hay at 0.9 ppm; and
wheat, straw at 0.50 ppm. That
document referenced a summary of the
petition prepared by Syngenta Crop
Protection, LLC., the registrant, which is
available in the docket, https://
www.regulations.gov. There were no
comments received in response to the
notice of filing.
Based upon review of the data
supporting the petition, EPA has revised
the proposed tolerances to wheat, forage
at 0.40 ppm; wheat, hay at 0.80 ppm;
wheat, bran at 0.07 ppm; grain,
aspirated fractions at 0.30 ppm; and
barley, straw at 0.40 ppm. EPA has
increased the existing tolerances to
cattle, meat byproducts at 2.0 ppm; goat,
meat byproducts at 2.0 ppm; sheep,
meat byproducts at 2.0 ppm; horse, meat
byproducts; at 2.0 ppm; and hog, meat
byproducts at 0.40 ppm. EPA has
determined that tolerances are not
needed to be established for barley,
germ and wheat, germ. The reason for
these changes are explained in Unit
IV.C.
III. Aggregate Risk Assessment and
Determination of Safety
Section 408(b)(2)(A)(i) of FFDCA
allows EPA to establish a tolerance (the
legal limit for a pesticide chemical
residue in or on a food) only if EPA
determines that the tolerance is ‘‘safe.’’
Section 408(b)(2)(A)(ii) of FFDCA
PO 00000
Frm 00057
Fmt 4700
Sfmt 4700
86961
defines ‘‘safe’’ to mean that ‘‘there is a
reasonable certainty that no harm will
result from aggregate exposure to the
pesticide chemical residue, including
all anticipated dietary exposures and all
other exposures for which there is
reliable information.’’ This includes
exposure through drinking water and in
residential settings, but does not include
occupational exposure. Section
408(b)(2)(C) of FFDCA requires EPA to
give special consideration to exposure
of infants and children to the pesticide
chemical residue in establishing a
tolerance and to ‘‘ensure that there is a
reasonable certainty that no harm will
result to infants and children from
aggregate exposure to the pesticide
chemical residue. . . .’’
Consistent with FFDCA section
408(b)(2)(D), and the factors specified in
FFDCA section 408(b)(2)(D), EPA has
reviewed the available scientific data
and other relevant information in
support of this action. EPA has
sufficient data to assess the hazards of
and to make a determination on
aggregate exposure for bicyclopyrone
including exposure resulting from the
tolerances established by this action.
EPA’s assessment of exposures and risks
associated with bicyclopyrone follows.
A. Toxicological Profile
EPA has evaluated the available
toxicity data and considered its validity,
completeness, and reliability as well as
the relationship of the results of the
studies to human risk. EPA has also
considered available information
concerning the variability of the
sensitivities of major identifiable
subgroups of consumers, including
infants and children.
The effects of bicyclopyrone are
indicative of inhibition of 4hydroxyphenylpyruvate dioxygenase
(HPPD). Plasma tyrosine levels were
consistently elevated in rats, rabbits,
and dogs (levels in mice were not
tested). Consistent with these elevated
tyrosine levels, ocular effects (corneal
opacity, keratitis) were observed for
subchronic and chronic durations
through the oral and dermal routes in
rats, which was the most sensitive
species tested (minor instances in dogs).
There were also increased incidences of
thyroid follicular hyperplasia and a
chronic progressive nephropathy.
While minor instances of ocular
effects were observed in dogs, different
toxicological effects were generally
observed. For subchronic oral exposure,
clinical signs (moderate hypoactivity,
slightly unsteady gait, increased heart
rate, regurgitation, and vomiting) were
observed, and clinical pathological
indicators of toxicity occurred in the eye
E:\FR\FM\02DER1.SGM
02DER1
jstallworth on DSK7TPTVN1PROD with RULES
86962
Federal Register / Vol. 81, No. 232 / Friday, December 2, 2016 / Rules and Regulations
and the thymus. Following chronic
exposure, there was a dose-dependent
increase in chromatolysis and swelling
of selected neurons in the dorsal root
ganglia, and degeneration of nerve fibers
in the spinal nerve roots in both sexes.
In one female dog at the high dose,
corneal opacity and light sensitivity
were observed.
Across the database, there were
decreased absolute body weights (the
only finding in mice for any duration)
and food consumption. There were no
signs of immunotoxicity or
neurotoxicity in rodents.
Bicyclopyrone treatment resulted in
developmental toxicity in both rats and
rabbits, and there was an increased
quantitative fetal susceptibility in both
species tested. In rats, maternal toxicity
was not observed up to 1,000 milligram/
kilogram/day (mg/kg/day). Fetal effects
occurred at all doses (≥100 mg/kg/day),
and manifested as skeletal variations
(increased incidences of full or
rudimentary supernumerary ribs, pelvic
girdle malpositioned caudal, costal
cartilage 11 long). In New Zealand
White rabbits, maternal effects consisted
of mortality/moribundity in conjunction
with minimal food consumption at 200
mg/kg/day. Fetal effects once again
occurred at all doses tested (≥10 mg/kg/
day). The sole fetal effect at the lowest
dose tested was the appearance of the
27th presacral vertebrae. There were
two studies in Himalayan rabbits. In
both studies, maternal effects consisted
of macroscopic findings in the stomach
wall and an increased incidence of postimplantation loss at the 250 mg/kg/day
dose level. In the first study, fetal effects
occurred starting at 50 mg/kg/day and
consisted of skeletal variations
(increased incidence of the 27th
prepelvic vertebra and malpositioned
pelvic girdle). In the second study, the
increased quantitative fetal
susceptibility was not observed due to
a change in the dose selection. Fetal
effects occurred at 250 mg/kg/day and
consisted of external, visceral, and
skeletal abnormalities, and visceral
variations, skeletal, bone and cartilage
variations. In total, the effects in these
studies are consistent with effects of
other chemicals in this class.
In the two-generation reproductive
study in rats, ocular toxicity occurred in
parents and offspring and there was no
increased offspring susceptibility of any
kind. Reproductive effects included
changes in sperm parameters, and a
decrease of precoital interval.
To determine the mechanism for the
thyroid hyperplasia observed in the
chronic/carcinogenicity study in rats,
two mode-of-action studies were
performed. In the in vitro study,
VerDate Sep<11>2014
14:49 Dec 01, 2016
Jkt 241001
bicyclopyrone was negative for thyroid
peroxidase inhibition. The results from
the in vivo study suggested that the
observed thyroid hyperplasia was the
result of increased metabolism of
thyroid hormones indicated by: (1)
Decreased plasma T3 and T4 levels, (2)
increased thyroid follicular cell
hypertrophy, (3) increased liver weights
associated, and (4) increased
hepatocellular centrilobular
hypertrophy and increased hepatic
uridine diphosphate glucuronyl
transferase (UDPGT) activities.
Bicyclopyrone is categorized as having
low acute lethality via all routes of
administration. Bicyclopyrone produces
minimal eye irritation and mild acute
inhalation toxicity.
Two adequate carcinogenicity studies
were submitted. One study conducted
on rats showed the presence of rare
ocular tumors in male rats only. The
corneal tumors observed in male rats are
(1) treatment related, (2) found at doses
that were considered to be adequate and
not excessive for assessing
carcinogenicity, (3) there are no
concerns for mutagenicity or
genotoxicity, and (4) are supported by
structure-activity relationship (SAR)
data for another HPPD inhibitor,
tembotrione. Another study conducted
on mice showed lung tumors, which are
not considered treatment related.
Because the tumors are found only in
one species and only in males,
consistent with the Agency guidelines
for carcinogen risk assessment, the
Agency has classified bicyclopyrone as
‘‘suggestive evidence of cancer’’ and has
determined that quantification of
bicyclopyrone’s carcinogenic potential
is not required. A non-linear approach
(i.e., reference dose (RfD)) will
adequately protect for all chronic
toxicity, including carcinogenicity that
could result from exposure to
bicyclopyrone. Using EPA’s non-linear
approach, the 1000X combined
uncertainty factor used to calculate the
chronic RfD/chronic populationadjusted dose for the chronic dietary
assessment, generates a dose which is
10,000-fold lower than the dose at
which the ocular tumors were not
observed and is thus protective of their
potential formation.
Specific information on the studies
received and the nature of the adverse
effects caused by bicyclopyrone as well
as the no-observed-adverse-effect-level
(NOAEL) and the lowest-observedadverse-effect-level (LOAEL) from the
toxicity studies can be found at https://
www.regulations.gov in document titled
‘‘Bicyclopyrone: Human Health Risk
Assessment for the Section 3
Registration Action on Cereals (Wheat
PO 00000
Frm 00058
Fmt 4700
Sfmt 4700
and Barley)’’ at pp. 29–34 in docket ID
number EPA–HQ–OPP–2015–0560.
B. Toxicological Points of Departure/
Levels of Concern
Once a pesticide’s toxicological
profile is determined, EPA identifies
toxicological points of departure (POD)
and levels of concern to use in
evaluating the risk posed by human
exposure to the pesticide. For hazards
that have a threshold below which there
is no appreciable risk, the toxicological
POD is used as the basis for derivation
of reference values for risk assessment.
PODs are developed based on a careful
analysis of the doses in each
toxicological study to determine the
dose at which the NOAEL and the
LOAEL are identified. Uncertainty/
safety factors are used in conjunction
with the POD to calculate a safe
exposure level—generally referred to as
a population-adjusted dose (PAD) or a
RfD—and a safe margin of exposure
(MOE). For non-threshold risks, the
Agency assumes that any amount of
exposure will lead to some degree of
risk. Thus, the Agency estimates risk in
terms of the probability of an occurrence
of the adverse effect expected in a
lifetime. For more information on the
general principles EPA uses in risk
characterization and a complete
description of the risk assessment
process, see https://www.epa.gov/
pesticides/factsheets/riskassess.htm. A
summary of the toxicological endpoints
for bicyclopyrone used for human risk
assessment is discussed in Unit III. B of
the final rule published in the Federal
Register of April 23, 2015 (80 FR 22648)
(FRL–9926–66).
C. Exposure Assessment
1. Dietary exposure from food and
feed uses. In evaluating dietary
exposure to bicyclopyrone, EPA
considered exposure under the
petitioned-for tolerances as well as all
existing bicyclopyrone tolerances in 40
CFR 180.682. EPA assessed dietary
exposures from bicyclopyrone in food as
follows:
i. Acute exposure. Quantitative acute
dietary exposure and risk assessments
are performed for a food-use pesticide,
if a toxicological study has indicated the
possibility of an effect of concern
occurring as a result of a 1-day or single
exposure. Such effects were identified
for bicyclopyrone. In estimating acute
dietary exposure, EPA used food
consumption information from the
United States Department of Agriculture
(USDA) 2003–2008 Nationwide
Continuing Surveys of Food Intake by
Individuals (CSFII). The acute dietary
analysis was conducted for
E:\FR\FM\02DER1.SGM
02DER1
jstallworth on DSK7TPTVN1PROD with RULES
Federal Register / Vol. 81, No. 232 / Friday, December 2, 2016 / Rules and Regulations
bicyclopyrone assuming tolerance level
residues, default processing factors, and
100% crop treatment (PCT) information.
ii. Chronic exposure. In conducting
the chronic dietary exposure assessment
EPA used the food consumption data
from the USDA 2003–2008 CSFII. The
chronic dietary exposure assessment
was conducted for bicyclopyrone
assuming average field trial residues for
crops, average empirical processing
factors, anticipated residues for
livestock commodities, and PCT
estimates for some commodities.
iii. Cancer. Based on the data
summarized in Unit III.A., EPA has
determined that a separate cancer
exposure assessment does not need to
be conducted.
iv. Anticipated residue and percent
crop treated (PCT) information. Section
408(b)(2)(E) of FFDCA authorizes EPA
to use available data and information on
the anticipated residue levels of
pesticide residues in food and the actual
levels of pesticide residues that have
been measured in food. If EPA relies on
such information, EPA must require
pursuant to FFDCA section 408(f)(1)
that data be provided 5 years after the
tolerance is established, modified, or
left in effect, demonstrating that the
levels in food are not above the levels
anticipated. For the present action, EPA
will issue such data call-ins as are
required by FFDCA section 408(b)(2)(E)
and authorized under FFDCA section
408(f)(1). Data will be required to be
submitted no later than 5 years from the
date of issuance of these tolerances.
Section 408(b)(2)(F) of FFDCA states
that the Agency may use data on the
actual percent of food treated for
assessing chronic dietary risk only if:
• Condition A: The data used are
reliable and provide a valid basis to
show what percentage of the food
derived from such crop is likely to
contain the pesticide residue.
• Condition B: The exposure estimate
does not underestimate exposure for any
significant subpopulation group.
• Condition C: Data are available on
pesticide use and food consumption in
a particular area, the exposure estimate
does not understate exposure for the
population in such area.
In addition, the Agency must provide
for periodic evaluation of any estimates
used. To provide for the periodic
evaluation of the estimate of PCT as
required by FFDCA section 408(b)(2)(F),
EPA may require registrants to submit
data on PCT.
The Agency estimated the PCT for
existing uses as follows: The chronic
analysis incorporated the following PCT
estimates: Field corn, 40% and sweet/
popcorn, 35%. The PCT for livestock
VerDate Sep<11>2014
14:49 Dec 01, 2016
Jkt 241001
commodities is based on the PCT
estimate value for the livestock feed
item used in the dietary burden with the
highest PCT (field corn, 40%).
In most cases, EPA uses available data
from United States Department of
Agriculture/National Agricultural
Statistics Service (USDA/NASS),
proprietary market surveys, and the
National Pesticide Use Database for the
chemical/crop combination for the most
recent 6–7 years. EPA uses an average
PCT for chronic dietary risk analysis.
The average PCT figure for each existing
use is derived by combining available
public and private market survey data
for that use, averaging across all
observations, and rounding to the
nearest 5%, except for those situations
in which the average PCT is less than
one. In those cases, 1% is used as the
average PCT and 2.5% is used as the
maximum PCT. EPA uses a maximum
PCT for acute dietary risk analysis. The
maximum PCT figure is the highest
observed maximum value reported
within the recent 6 years of available
public and private market survey data
for the existing use and rounded up to
the nearest multiple of 5%.
The Agency estimated the PCT for
new uses as follows: The chronic
analysis incorporated the following PCT
estimates: Barley, 5% and wheat, 1%.
The Agency believes that the three
conditions discussed in Unit III.C.1.iv.
have been met. With respect to
Condition A, PCT estimates are derived
from Federal and private market survey
data, which are reliable and have a valid
basis. The Agency is reasonably certain
that the percentage of the food treated
is not likely to be an underestimation.
As to Conditions B and C, regional
consumption information and
consumption information for significant
subpopulations is taken into account
through EPA’s computer-based model
for evaluating the exposure of
significant subpopulations including
several regional groups. Use of this
consumption information in EPA’s risk
assessment process ensures that EPA’s
exposure estimate does not understate
exposure for any significant
subpopulation group and allows the
Agency to be reasonably certain that no
regional population is exposed to
residue levels higher than those
estimated by the Agency. Other than the
data available through national food
consumption surveys, EPA does not
have available reliable information on
the regional consumption of food to
which bicyclopyrone may be applied in
a particular area.
2. Dietary exposure from drinking
water. The Agency used screening level
water exposure models in the dietary
PO 00000
Frm 00059
Fmt 4700
Sfmt 4700
86963
exposure analysis and risk assessment
for bicyclopyrone in drinking water.
These simulation models take into
account data on the physical, chemical,
and fate/transport characteristics of
bicyclopyrone. Further information
regarding EPA drinking water models
used in pesticide exposure assessment
can be found at https://www.epa.gov/
oppefed1/models/water/index.htm.
The Surface Water Concentration
Calculator (SWCC) computer model was
used to generate surface water Estimated
Drinking Water Concentrations
(EDWCs), while the Pesticide Root Zone
Model for Groundwater (PRZM–GW)
and the Screening Concentration in
Ground Water (SCI–GROW) models
were used to generate groundwater
EDWCs. The maximum acute, chronic,
and cancer surface water EDWCs
associated with bicyclopyrone use on
wheat and barley were 3.43, 1.02, and
0.46 parts per billion (ppb),
respectively. For groundwater sources of
drinking water, the maximum acute,
chronic and cancer EDWCs of
bicyclopyrone in shallow groundwater
from PRZM–GW were 4.82, 4.2, and 2.1
ppb, respectively. EDWCs of 4.82 ppb
and 4.2 ppb were used in the acute and
chronic analyses, respectively.
3. From non-dietary exposure. The
term ‘‘residential exposure’’ is used in
this document to refer to nonoccupational, non-dietary exposure
(e.g., for lawn and garden pest control,
indoor pest control, termiticides, and
flea and tick control on pets).
Bicyclopyrone is not registered for any
specific use patterns that would result
in residential exposure.
4. Cumulative effects from substances
with a common mechanism of toxicity.
Section 408(b)(2)(D)(v) of FFDCA
requires that, when considering whether
to establish, modify, or revoke a
tolerance, the Agency consider
‘‘available information’’ concerning the
cumulative effects of a particular
pesticide’s residues and ‘‘other
substances that have a common
mechanism of toxicity.’’
There are marked differences among
species in the ocular toxicity associated
with bicyclopyrone’s mechanism of
toxicity, the inhibition of HPPD. Ocular
effects following treatment with HPPD
inhibitor herbicides are seen in the rat
but not in the mouse. Monkeys also
seem to be recalcitrant to the ocular
toxicity induced by HPPD inhibition.
One explanation for this species-specific
response in ocular opacity may be
related to species differences in the
clearance of tyrosine. A metabolic
pathway exists to remove tyrosine from
the blood that involves the liver enzyme
tyrosine aminotransferase (TAT). In
E:\FR\FM\02DER1.SGM
02DER1
86964
Federal Register / Vol. 81, No. 232 / Friday, December 2, 2016 / Rules and Regulations
jstallworth on DSK7TPTVN1PROD with RULES
contrast to rats where ocular toxicity is
observed following exposure to HPPDinhibiting herbicides, mice and humans
are unlikely to achieve the levels of
plasma tyrosine necessary to produce
ocular opacities because the activity of
TAT in these species is much greater
compared to rats.
HPPD inhibitors (e.g., nitisinone) are
used as an effective therapeutic agent to
treat patients suffering from rare genetic
diseases of tyrosine catabolism.
Treatment starts in childhood but is
often sustained throughout patient’s
lifetime. The human experience
indicates that a therapeutic dose (1 mg/
kg/day dose) of nitisinone has an
excellent safety record in infants,
children, and adults and that serious
adverse health outcomes have not been
observed in a population followed for
approximately a decade. Rarely, ocular
effects are seen in patients with high
plasma tyrosine levels; however, these
effects are transient and can be readily
reversed upon adherence to a restricted
protein diet. This observation indicates
that an HPPD inhibitor in and of itself
cannot easily overwhelm the tyrosineclearance mechanism in humans.
Therefore, exposures to
environmental residues of HPPDinhibiting herbicides are unlikely to
result in the high blood levels of
tyrosine and ocular toxicity in humans
due to an efficient metabolic process to
handle excess tyrosine. The EPA
continues to study the complex
relationships between elevated tyrosine
levels and biological effects in various
species. In the future, assessments of
HPPD-inhibiting herbicides may
consider more appropriate models and
cross species extrapolation methods.
Therefore, EPA has not conducted
cumulative risk assessment with other
HPPD inhibitors.
D. Safety Factor for Infants and
Children
1. In general. Section 408(b)(2)(C) of
FFDCA provides that EPA shall apply
an additional tenfold (10X) margin of
safety for infants and children in the
case of threshold effects to account for
prenatal and postnatal toxicity and the
completeness of the database on toxicity
and exposure unless EPA determines
based on reliable data that a different
margin of safety will be safe for infants
and children. This additional margin of
safety is commonly referred to as the
Food Quality Protection Act Safety
Factor (FQPA SF). In applying this
provision, EPA either retains the default
value of 10X, or uses a different
additional safety factor when reliable
data available to EPA support the choice
of a different factor.
VerDate Sep<11>2014
14:49 Dec 01, 2016
Jkt 241001
2. The FQPA SF is retained at 10X for
all exposure scenarios based on use of
a LOAEL for the points of departure.
The toxicology database for
bicyclopyrone is adequate for
characterizing toxicity and
quantification of risk for food and nonfood uses; however, a LOAEL from the
New Zealand white rabbit
developmental and chronic/
carcinogenicity rat toxicity studies has
been used as the POD for several
scenarios.
There is no evidence of neurotoxicity
in either of the neurotoxicity screening
batteries, but there are effects in the
chronic dog study. The level of concern
is low, however, since the study and
POD chosen for the chronic dietary
exposure scenario is protective of these
effects. There is evidence of increased
quantitative fetal susceptibility
following in utero exposure in both rats
and rabbits; however, these effects are
well characterized and the selected
endpoints are protective of the observed
fetal effects. Lastly, there are no residual
uncertainties in the exposure database.
E. Aggregate Risks and Determination of
Safety
EPA determines whether acute and
chronic dietary pesticide exposures are
safe by comparing aggregate exposure
estimates to the acute PAD (aPAD) and
chronic PAD (cPAD). For linear cancer
risks, EPA calculates the lifetime
probability of acquiring cancer given the
estimated aggregate exposure. Short-,
intermediate-, and chronic-term risks
are evaluated by comparing the
estimated aggregate food, water, and
residential exposure to the appropriate
PODs to ensure that an adequate MOE
exists.
1. Acute risk. Using the exposure
assumptions discussed in this unit for
acute exposure, the acute dietary
exposure from food and water to
bicyclopyrone will occupy 4.6% of the
aPAD for females 13–49 years old, the
population group receiving the greatest
exposure.
2. Chronic risk. Using the exposure
assumptions described in this unit for
chronic exposure, EPA has concluded
that chronic exposure to bicyclopyrone
from food and water will utilize 90% of
the cPAD for children <1 years old the
population group receiving the greatest
exposure. There are no residential uses
for bicyclopyrone.
3. Short-term risk. A short-term
adverse effect was identified; however,
bicyclopyrone is not registered for any
use patterns that would result in shortterm residential exposure. Short-term
risk is assessed based on short-term
residential exposure plus chronic
PO 00000
Frm 00060
Fmt 4700
Sfmt 4700
dietary exposure. Because there is no
short-term residential exposure and
chronic dietary exposure has already
been assessed under the appropriately
protective cPAD (which is at least as
protective as the POD used to assess
short-term risk), no further assessment
of short-term risk is necessary, and EPA
relies on the chronic dietary risk
assessment for evaluating short-term
risk for bicyclopyrone.
4. Intermediate-term risk. An
intermediate-term adverse effect was
identified; however, bicyclopyrone is
not registered for any use patterns that
would result in intermediate-term
residential exposure. Intermediate-term
risk is assessed based on intermediateterm residential exposure plus chronic
dietary exposure. Because there is no
intermediate-term residential exposure
and chronic dietary exposure has
already been assessed under the
appropriately protective cPAD (which is
at least as protective as the POD used to
assess intermediate-term risk), no
further assessment of intermediate-term
risk is necessary, and EPA relies on the
chronic dietary risk assessment for
evaluating intermediate-term risk for
bicyclopyrone.
5. Aggregate cancer risk for U.S.
population. Because the Agency has
determined that the chronic RfD will be
protective of any potential cancer risk
and there is not a chronic risks do not
exceed the Agency’s level of concern,
EPA concludes that there is not a
concern for cancer risk from exposure to
bicyclopyrone.
6. Determination of safety. Based on
these risk assessments, EPA concludes
that there is a reasonable certainty that
no harm will result to the general
population, or to infants and children
from aggregate exposure to
bicyclopyrone residues.
IV. Other Considerations
A. Analytical Enforcement Methodology
Adequate enforcement methodology
liquid chromatography-mass
spectroscopy/mass spectroscopy (LCMS/MS) methods for tolerance
enforcement have been developed and
independently validated. For all
matrices and analytes, the level of
quantification (LOQ), defined as the
lowest spiking level where acceptable
precision and accuracy data were
obtained, was determined to be 0.01
ppm for each of the common moieties,
SYN503780 and CSCD686480, for a
combined LOQ of 0.02 ppm is available
to enforce the tolerance expression.
The method may be requested from:
Chief, Analytical Chemistry Branch,
Environmental Science Center, 701
E:\FR\FM\02DER1.SGM
02DER1
Federal Register / Vol. 81, No. 232 / Friday, December 2, 2016 / Rules and Regulations
Mapes Rd., Ft. Meade, MD 20755–5350;
telephone number: (410) 305–2905;
email address: residuemethods@
epa.gov.
jstallworth on DSK7TPTVN1PROD with RULES
B. International Residue Limits
In making its tolerance decisions, EPA
seeks to harmonize U.S. tolerances with
international standards whenever
possible, consistent with U.S. food
safety standards and agricultural
practices. EPA considers the
international maximum residue limits
(MRLs) established by the Codex
Alimentarius Commission (Codex), as
required by FFDCA section 408(b)(4).
The Codex Alimentarius is a joint
United Nations Food and Agriculture
Organization/World Health
Organization food standards program,
and it is recognized as an international
food safety standards-setting
organization in trade agreements to
which the United States is a party. EPA
may establish a tolerance that is
different from a Codex MRL; however,
FFDCA section 408(b)(4) requires that
EPA explain the reasons for departing
from the Codex level. The Codex has not
established a MRL for bicyclopyrone.
C. Revisions to Petitioned-For
Tolerances
The requested tolerance levels for
some wheat and barley raw agricultural
commodities (RAC) differ slightly from
those being set by the EPA. Although
both the petitioner and EPA have used
the Organization for Economic
Cooperation and Development (OECD)
calculation procedures to determine
tolerance levels, EPA determined that
some of the field residue trials were not
independent, thus resulting in different
inputs. Using the highest average RAC
residues and average processing factors,
EPA calculated tolerance levels for
processed commodities that were
generally lower than those requested
and determined that the requested
tolerances for residues in/on wheat and
barley germ are not necessary as the
expected residue levels are covered by
the RAC tolerance levels.
Consistent with 40 CFR 180.6, EPA is
amending existing livestock commodity
tolerances as necessary. As a result of
increased dietary burdens resulting from
the use on wheat and barley
commodities, the existing tolerances of
1.5 ppm for residues in/on the meat
byproducts of cattle, goats, horses, and
sheep are increased to 2.0 ppm; and the
existing tolerance of 0.15 ppm for
residues in/on for hog meat byproducts
is increased to 0.40 ppm.
In addition, EPA changed the
commodity terminology for aspirated
grain fractions to grain, aspirated
VerDate Sep<11>2014
14:49 Dec 01, 2016
Jkt 241001
fractions in order to conform to terms
used in the Agency’s Food and Feed
Commodity Vocabulary and amended
the tolerance value for barley, hay from
0.3 ppm to 0.30 ppm to conform with
the Agency policy to carry tolerance
levels out two significant figures.
V. Conclusion
Therefore, tolerances are established
for residues of the herbicide
bicyclopyrone in or on barley, bran at
0.15 ppm; barley, grain, at 0.07 ppm;
barley, hay at 0.30 ppm; barley, straw at
0.40 ppm; cattle, meat byproducts at 2.0
ppm; goat, meat byproducts at 2.0 ppm;
grain, aspirated fractions at 0.30 ppm;
hog, meat byproducts at 0.40 ppm;
horse, meat byproducts at 2.0 ppm;
sheep, meat byproducts at 2.0 ppm;
wheat, bran at 0.07 ppm; wheat, forage
at 0.40 ppm; wheat, grain, at 0.04 ppm;
wheat, hay at 0.80 ppm; and wheat,
straw at 0.50 ppm.
VI. Statutory and Executive Order
Reviews
This action establishes tolerances
under FFDCA section 408(d) in
response to a petition submitted to the
Agency. The Office of Management and
Budget (OMB) has exempted these types
of actions from review under Executive
Order 12866, entitled ‘‘Regulatory
Planning and Review’’ (58 FR 51735,
October 4, 1993). Because this action
has been exempted from review under
Executive Order 12866, this action is
not subject to Executive Order 13211,
entitled ‘‘Actions Concerning
Regulations That Significantly Affect
Energy Supply, Distribution, or Use’’ (66
FR 28355, May 22, 2001) or Executive
Order 13045, entitled ‘‘Protection of
Children from Environmental Health
Risks and Safety Risks’’ (62 FR 19885,
April 23, 1997). This action does not
contain any information collections
subject to OMB approval under the
Paperwork Reduction Act (PRA) (44
U.S.C. 3501 et seq.), nor does it require
any special considerations under
Executive Order 12898, entitled
‘‘Federal Actions to Address
Environmental Justice in Minority
Populations and Low-Income
Populations’’ (59 FR 7629, February 16,
1994).
Since tolerances and exemptions that
are established on the basis of a petition
under FFDCA section 408(d), such as
the tolerance in this final rule, do not
require the issuance of a proposed rule,
the requirements of the Regulatory
Flexibility Act (RFA) (5 U.S.C. 601 et
seq.), do not apply.
This action directly regulates growers,
food processors, food handlers, and food
retailers, not States or tribes, nor does
PO 00000
Frm 00061
Fmt 4700
Sfmt 4700
86965
this action alter the relationships or
distribution of power and
responsibilities established by Congress
in the preemption provisions of FFDCA
section 408(n)(4). As such, the Agency
has determined that this action will not
have a substantial direct effect on States
or tribal governments, on the
relationship between the national
government and the States or tribal
governments, or on the distribution of
power and responsibilities among the
various levels of government or between
the Federal Government and Indian
tribes. Thus, the Agency has determined
that Executive Order 13132, entitled
‘‘Federalism’’ (64 FR 43255, August 10,
1999) and Executive Order 13175,
entitled ‘‘Consultation and Coordination
with Indian Tribal Governments’’ (65 FR
67249, November 9, 2000) do not apply
to this action. In addition, this action
does not impose any enforceable duty or
contain any unfunded mandate as
described under Title II of the Unfunded
Mandates Reform Act (UMRA) (2 U.S.C.
1501 et seq.).
This action does not involve any
technical standards that would require
Agency consideration of voluntary
consensus standards pursuant to section
12(d) of the National Technology
Transfer and Advancement Act
(NTTAA) (15 U.S.C. 272 note).
VII. Congressional Review Act
Pursuant to the Congressional Review
Act (5 U.S.C. 801 et seq.), EPA will
submit a report containing this rule and
other required information to the U.S.
Senate, the U.S. House of
Representatives, and the Comptroller
General of the United States prior to
publication of the rule in the Federal
Register. This action is not a ‘‘major
rule’’ as defined by 5 U.S.C. 804(2).
List of Subjects in 40 CFR Part 180
Environmental protection,
Administrative practice and procedure,
Agricultural commodities, Pesticides
and pests, Reporting and recordkeeping
requirements.
Dated: November 3, 2016.
Michael Goodis,
Acting Director, Registration Division, Office
of Pesticide Programs.
Therefore, 40 CFR chapter I is
amended as follows:
PART 180—[AMENDED]
1. The authority citation for part 180
continues to read as follows:
■
Authority: 21 U.S.C. 321(q), 346a and 371.
2. In § 180.682, revise the table in
paragraph (a)(1) to read as follows:
■
E:\FR\FM\02DER1.SGM
02DER1
86966
Federal Register / Vol. 81, No. 232 / Friday, December 2, 2016 / Rules and Regulations
§ 180.682 Bicyclopyrone; tolerances for
residues.
(a) * * *
(1) * * *
Parts per
million
Commodity
Barley, bran ..........................
Barley, grain .........................
Barley, hay ............................
Barley, straw .........................
Cattle, meat byproducts .......
Corn, field, forage .................
Corn, field, grain ...................
Corn, field, stover .................
Corn, pop, grain ....................
Corn, pop, stover ..................
Corn, sweet, forage ..............
Corn, sweet, kernel plus cob
with husks removed ..........
Corn, sweet, stover ..............
Goat, meat byproducts .........
Grain, aspirated fractions .....
Hog, meat byproducts ..........
Horse, meat byproducts .......
Sheep, meat byproducts ......
Sugarcane, cane 1 ................
Wheat, bran ..........................
Wheat, forage .......................
Wheat, grain .........................
Wheat, hay ...........................
Wheat, straw .........................
0.15
0.07
0.30
0.40
2.0
0.30
0.02
0.40
0.02
0.40
0.40
0.03
0.70
2.0
0.30
0.40
2.0
2.0
0.02
0.07
0.40
0.04
0.80
0.50
1 There are no U.S. Registration on Sugarcane as of March 13, 2015.
*
*
*
*
*
[FR Doc. 2016–29005 Filed 12–1–16; 8:45 am]
BILLING CODE 6560–50–P
DEPARTMENT OF COMMERCE
National Oceanic and Atmospheric
Administration
50 CFR Part 300
[Docket No. 160801681–6999–02]
RIN 0648–BG22
International Fisheries; Tuna and
Tuna-Like Species in the Eastern
Pacific Ocean; Silky Shark Fishing
Restrictions and Fish Aggregating
Device Data Collection and
Identification
National Marine Fisheries
Service (NMFS), National Oceanic and
Atmospheric Administration (NOAA),
Commerce.
ACTION: Final rule.
jstallworth on DSK7TPTVN1PROD with RULES
AGENCY:
NMFS is issuing regulations
under the Tuna Conventions Act to
implement certain provisions of two
Resolutions adopted by the InterAmerican Tropical Tuna Commission
(IATTC) in 2016: Resolution C–16–01
(Collection and Analyses of Data On
Fish-Aggregating Devices) and
SUMMARY:
VerDate Sep<11>2014
14:49 Dec 01, 2016
Jkt 241001
Resolution C–16–06 (Conservation
Measures for Shark Species, with
Special Emphasis on the Silky Shark
(Carcharhinus Falciformis) for the Years
2017, 2018, and 2019). Per Resolution
C–16–01, these regulations require the
owner or operator of a U.S. purse seine
vessel to ensure characters of a unique
code be marked indelibly on each fish
aggregating device (FAD) deployed or
modified on or after January 1, 2017, in
the IATTC Convention Area. The vessel
owner or operator must record and
submit information about the FAD, as
described in Annex I of Resolution C–
16–01. Per Resolution C–16–06, these
regulations prohibit the owner or
operator of a U.S. purse seine vessel
from retaining on board, transshipping,
landing, or storing, in part or whole,
carcasses of silky sharks caught by
purse-seine vessels in the IATTC
Convention Area. These regulations also
provide limits on the retained catch of
silky sharks caught in the IATTC
Convention Area. This rule is necessary
for the United States to satisfy its
obligations as a member of the IATTC.
DATES: This rule is effective January 1,
2017.
ADDRESSES: Copies of the Regulatory
Impact Review and other supporting
documents are available via the Federal
eRulemaking Portal: https://
www.regulations.gov, docket NOAA–
NMFS–2016–0106 or by contacting the
Regional Administrator, Barry A. Thom,
NMFS West Coast Region, 1201 NE.
Lloyd Boulevard, Suite 1100, Portland
Oregon, 97232–1274, or
RegionalAdministrator.WCRHMS@
noaa.gov.
FOR FURTHER INFORMATION CONTACT:
Rachael Wadsworth, NMFS, West Coast
Region, 562–980–4036.
SUPPLEMENTARY INFORMATION: On
October 11, 2016, NMFS published a
proposed rule in the Federal Register
(81 FR 70080) to implement certain
provisions of Resolutions C–16–01 and
C–16–06 adopted by the IATTC in 2016.
The proposed rule contained additional
background information, including
information on the IATTC, the
international obligations of the United
States as an IATTC member, and the
need for regulations. The 30-day public
comment period for the proposed rule
closed on November 10, 2016.
The final rule is implemented under
the Tuna Conventions Act (16 U.S.C.
951 et seq.), as amended on November
5, 2015, by title II of Public Law 114–
81. The recent amendments direct the
Secretary of Commerce, in consultation
with the Secretary of State, and, with
respect to enforcement measures, the
U.S. Coast Guard, to promulgate such
PO 00000
Frm 00062
Fmt 4700
Sfmt 4700
regulations as may be necessary to carry
out the United States’ obligations under
the Antigua Convention, including
recommendations and decisions
adopted by the IATTC. The authority of
the Secretary of Commerce to
promulgate such regulations has been
delegated to NMFS. This rule
implements certain provisions of
Resolutions C–16–01 and C–16–06 for
U.S. commercial fishing vessels that fish
for tuna or tuna-like species in the
IATTC Convention Area. The preamble
of the proposed rule included a detailed
description of the elements of this rule.
This rule includes four elements: Two
elements regarding FADs and two
elements regarding silky sharks. The
first element requires the owner or
operator of a U.S. purse seine vessel to
ensure characters of a unique code be
marked indelibly on each fish
aggregating device (FAD) deployed or
modified on or after January 1, 2017.
The vessel owner or operator must
select one of the following two options
for the unique code for each FAD: (1)
Obtain a unique code from NMFS West
Coast Region that NMFS has obtained
from the IATTC Secretariat, as specified
in Annex I of Resolution C–16–01 or (2)
use an existing unique identifier
associated with the FAD (e.g., the
manufacturer identification code for the
attached buoy).
The vessel owner or operator is
required to ensure the characters for the
unique code be at least five centimeters
in height on the upper portion of the
attached radio or satellite buoy in a
location that does not cover the solar
cells used to power the equipment. For
FADs without attached radio or satellite
buoys, the characters are required to be
marked indelibly on the uppermost or
emergent top portion of the FAD. In
other words, the vessel owner or
operator is required to ensure the
marking is durable and will not fade or
be erased (e.g., marked using an epoxybased paint or an equivalent in terms of
lasting ability) and visible at all times
during daylight. In circumstances where
the observer is unable to view the
unique code, the captain or crew is
required to assist the observer (e.g., by
providing the unique code of the FAD
to the observer).
The second element requires the
owner or operator of a vessel to record
and submit information about the FAD
to the address specified by the Highly
Migratory Species (HMS) Branch,
Sustainable Fisheries Division, NMFS
West Coast Region (Suite 4200, 501 W.
Ocean Blvd., Long Beach, CA 90802).
Owners and operators of a FAD are
required to record this information on
the standard form developed by the
E:\FR\FM\02DER1.SGM
02DER1
Agencies
[Federal Register Volume 81, Number 232 (Friday, December 2, 2016)]
[Rules and Regulations]
[Pages 86960-86966]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-29005]
=======================================================================
-----------------------------------------------------------------------
ENVIRONMENTAL PROTECTION AGENCY
40 CFR Part 180
[EPA-HQ-OPP-2015-0560; FRL-9954-63]
Bicyclopyrone; Pesticide Tolerances
AGENCY: Environmental Protection Agency (EPA).
ACTION: Final rule.
-----------------------------------------------------------------------
SUMMARY: This regulation establishes tolerances for residues of
bicyclopyrone in or on wheat and barley. Syngenta Crop Protection, LLC.
requested these tolerances under the Federal Food, Drug, and Cosmetic
Act (FFDCA).
DATES: This regulation is effective December 2, 2016. Objections and
requests for hearings must be received on or before January 31, 2017,
and must be filed in accordance with the instructions provided in 40
CFR part 178 (see also Unit I.C. of the SUPPLEMENTARY INFORMATION).
ADDRESSES: The docket for this action, identified by docket
identification (ID) number EPA-HQ-OPP-2015-0560, is available at https://www.regulations.gov or at the Office of Pesticide Programs Regulatory
Public Docket (OPP Docket) in the Environmental Protection Agency
Docket Center (EPA/DC), West William Jefferson Clinton Bldg., Rm. 3334,
1301 Constitution Ave. NW., Washington, DC 20460-0001. The Public
Reading Room is open from 8:30 a.m. to 4:30 p.m., Monday through
Friday, excluding legal holidays. The telephone number for the Public
Reading Room is (202) 566-1744, and the telephone number for the OPP
Docket is (703) 305-5805. Please review the visitor instructions and
additional information about the docket available at https://www.epa.gov/dockets.
FOR FURTHER INFORMATION CONTACT: Michael Goodis, Registration Division
(7505P), Office of Pesticide Programs, Environmental Protection Agency,
1200 Pennsylvania Ave. NW., Washington, DC 20460-0001; main telephone
number: (703) 305-7090; email address: RDFRNotices@epa.gov.
SUPPLEMENTARY INFORMATION:
I. General Information
A. Does this action apply to me?
You may be potentially affected by this action if you are an
agricultural producer, food manufacturer, or pesticide manufacturer.
The following list of North American Industrial Classification System
(NAICS) codes is not intended to be exhaustive, but rather provides a
guide to help readers determine whether this document
[[Page 86961]]
applies to them. Potentially affected entities may include:
Crop production (NAICS code 111).
Animal production (NAICS code 112).
Food manufacturing (NAICS code 311).
Pesticide manufacturing (NAICS code 32532).
B. How can I get electronic access to other related information?
You may access a frequently updated electronic version of EPA's
tolerance regulations at 40 CFR part 180 through the Government
Printing Office's e-CFR site at https://www.ecfr.gov/cgi-bin/text-idx?&c=ecfr&tpl=/ecfrbrowse/Title40/40tab_02.tpl.
C. How can I file an objection or hearing request?
Under FFDCA section 408(g), 21 U.S.C. 346a, any person may file an
objection to any aspect of this regulation and may also request a
hearing on those objections. You must file your objection or request a
hearing on this regulation in accordance with the instructions provided
in 40 CFR part 178. To ensure proper receipt by EPA, you must identify
docket ID number EPA-HQ-OPP-2015-0560 in the subject line on the first
page of your submission. All objections and requests for a hearing must
be in writing, and must be received by the Hearing Clerk on or before
January 31, 2017. Addresses for mail and hand delivery of objections
and hearing requests are provided in 40 CFR 178.25(b).
In addition to filing an objection or hearing request with the
Hearing Clerk as described in 40 CFR part 178, please submit a copy of
the filing (excluding any Confidential Business Information (CBI)) for
inclusion in the public docket. Information not marked confidential
pursuant to 40 CFR part 2 may be disclosed publicly by EPA without
prior notice. Submit the non-CBI copy of your objection or hearing
request, identified by docket ID number EPA-HQ-OPP-2015-0560, by one of
the following methods:
Federal eRulemaking Portal: https://www.regulations.gov.
Follow the online instructions for submitting comments. Do not submit
electronically any information you consider to be CBI or other
information whose disclosure is restricted by statute.
Mail: OPP Docket, Environmental Protection Agency Docket
Center (EPA/DC), (28221T), 1200 Pennsylvania Ave. NW., Washington, DC
20460-0001.
Hand Delivery: To make special arrangements for hand
delivery or delivery of boxed information, please follow the
instructions at https://www.epa.gov/dockets/contacts.html.
Additional instructions on commenting or visiting the docket, along
with more information about dockets generally, is available at https://www.epa.gov/dockets.
II. Summary of Petitioned-For Tolerance
In the Federal Register of October 21, 2015 (80 FR 63731) (FRL-
9935-29), EPA issued a document pursuant to FFDCA section 408(d)(3), 21
U.S.C. 346a(d)(3), announcing the filing of a pesticide petition (PP
5F8374) by Syngenta Crop Protection, LLC., P.O. Box 18300, Greensboro,
NC 27419. The petition requested that 40 CFR part 180.682 be amended by
establishing tolerances for residues of the herbicide, bicyclopyrone:
4-hydroxy-3-{2-[(2-methoxyethoxy) methyl{time} -6-(trifluoromethyl)-3-
pyridylcarbonyl{time} bicyclo oct-3-en-2-one, in or on the raw
agricultural commodities: Barley, bran at 0.15 parts per million (ppm);
barley, germ at 0.10 ppm; barley, grain, at 0.07 ppm; barley, hay at
0.3 ppm; barley, straw at 0.50 ppm; wheat, aspirated grain fractions at
0.50 ppm; wheat, bran at 0.15 ppm; wheat, forage at 0.50 ppm; wheat,
germ at 0.10 ppm; wheat, grain, at 0.04 ppm; wheat, hay at 0.9 ppm; and
wheat, straw at 0.50 ppm. That document referenced a summary of the
petition prepared by Syngenta Crop Protection, LLC., the registrant,
which is available in the docket, https://www.regulations.gov. There
were no comments received in response to the notice of filing.
Based upon review of the data supporting the petition, EPA has
revised the proposed tolerances to wheat, forage at 0.40 ppm; wheat,
hay at 0.80 ppm; wheat, bran at 0.07 ppm; grain, aspirated fractions at
0.30 ppm; and barley, straw at 0.40 ppm. EPA has increased the existing
tolerances to cattle, meat byproducts at 2.0 ppm; goat, meat byproducts
at 2.0 ppm; sheep, meat byproducts at 2.0 ppm; horse, meat byproducts;
at 2.0 ppm; and hog, meat byproducts at 0.40 ppm. EPA has determined
that tolerances are not needed to be established for barley, germ and
wheat, germ. The reason for these changes are explained in Unit IV.C.
III. Aggregate Risk Assessment and Determination of Safety
Section 408(b)(2)(A)(i) of FFDCA allows EPA to establish a
tolerance (the legal limit for a pesticide chemical residue in or on a
food) only if EPA determines that the tolerance is ``safe.'' Section
408(b)(2)(A)(ii) of FFDCA defines ``safe'' to mean that ``there is a
reasonable certainty that no harm will result from aggregate exposure
to the pesticide chemical residue, including all anticipated dietary
exposures and all other exposures for which there is reliable
information.'' This includes exposure through drinking water and in
residential settings, but does not include occupational exposure.
Section 408(b)(2)(C) of FFDCA requires EPA to give special
consideration to exposure of infants and children to the pesticide
chemical residue in establishing a tolerance and to ``ensure that there
is a reasonable certainty that no harm will result to infants and
children from aggregate exposure to the pesticide chemical residue. . .
.''
Consistent with FFDCA section 408(b)(2)(D), and the factors
specified in FFDCA section 408(b)(2)(D), EPA has reviewed the available
scientific data and other relevant information in support of this
action. EPA has sufficient data to assess the hazards of and to make a
determination on aggregate exposure for bicyclopyrone including
exposure resulting from the tolerances established by this action.
EPA's assessment of exposures and risks associated with bicyclopyrone
follows.
A. Toxicological Profile
EPA has evaluated the available toxicity data and considered its
validity, completeness, and reliability as well as the relationship of
the results of the studies to human risk. EPA has also considered
available information concerning the variability of the sensitivities
of major identifiable subgroups of consumers, including infants and
children.
The effects of bicyclopyrone are indicative of inhibition of 4-
hydroxyphenylpyruvate dioxygenase (HPPD). Plasma tyrosine levels were
consistently elevated in rats, rabbits, and dogs (levels in mice were
not tested). Consistent with these elevated tyrosine levels, ocular
effects (corneal opacity, keratitis) were observed for subchronic and
chronic durations through the oral and dermal routes in rats, which was
the most sensitive species tested (minor instances in dogs). There were
also increased incidences of thyroid follicular hyperplasia and a
chronic progressive nephropathy.
While minor instances of ocular effects were observed in dogs,
different toxicological effects were generally observed. For subchronic
oral exposure, clinical signs (moderate hypoactivity, slightly unsteady
gait, increased heart rate, regurgitation, and vomiting) were observed,
and clinical pathological indicators of toxicity occurred in the eye
[[Page 86962]]
and the thymus. Following chronic exposure, there was a dose-dependent
increase in chromatolysis and swelling of selected neurons in the
dorsal root ganglia, and degeneration of nerve fibers in the spinal
nerve roots in both sexes. In one female dog at the high dose, corneal
opacity and light sensitivity were observed.
Across the database, there were decreased absolute body weights
(the only finding in mice for any duration) and food consumption. There
were no signs of immunotoxicity or neurotoxicity in rodents.
Bicyclopyrone treatment resulted in developmental toxicity in both
rats and rabbits, and there was an increased quantitative fetal
susceptibility in both species tested. In rats, maternal toxicity was
not observed up to 1,000 milligram/kilogram/day (mg/kg/day). Fetal
effects occurred at all doses (>=100 mg/kg/day), and manifested as
skeletal variations (increased incidences of full or rudimentary
supernumerary ribs, pelvic girdle malpositioned caudal, costal
cartilage 11 long). In New Zealand White rabbits, maternal effects
consisted of mortality/moribundity in conjunction with minimal food
consumption at 200 mg/kg/day. Fetal effects once again occurred at all
doses tested (>=10 mg/kg/day). The sole fetal effect at the lowest dose
tested was the appearance of the 27th presacral vertebrae. There were
two studies in Himalayan rabbits. In both studies, maternal effects
consisted of macroscopic findings in the stomach wall and an increased
incidence of post-implantation loss at the 250 mg/kg/day dose level. In
the first study, fetal effects occurred starting at 50 mg/kg/day and
consisted of skeletal variations (increased incidence of the 27th
prepelvic vertebra and malpositioned pelvic girdle). In the second
study, the increased quantitative fetal susceptibility was not observed
due to a change in the dose selection. Fetal effects occurred at 250
mg/kg/day and consisted of external, visceral, and skeletal
abnormalities, and visceral variations, skeletal, bone and cartilage
variations. In total, the effects in these studies are consistent with
effects of other chemicals in this class.
In the two-generation reproductive study in rats, ocular toxicity
occurred in parents and offspring and there was no increased offspring
susceptibility of any kind. Reproductive effects included changes in
sperm parameters, and a decrease of precoital interval.
To determine the mechanism for the thyroid hyperplasia observed in
the chronic/carcinogenicity study in rats, two mode-of-action studies
were performed. In the in vitro study, bicyclopyrone was negative for
thyroid peroxidase inhibition. The results from the in vivo study
suggested that the observed thyroid hyperplasia was the result of
increased metabolism of thyroid hormones indicated by: (1) Decreased
plasma T3 and T4 levels, (2) increased thyroid follicular cell
hypertrophy, (3) increased liver weights associated, and (4) increased
hepatocellular centrilobular hypertrophy and increased hepatic uridine
diphosphate glucuronyl transferase (UDPGT) activities. Bicyclopyrone is
categorized as having low acute lethality via all routes of
administration. Bicyclopyrone produces minimal eye irritation and mild
acute inhalation toxicity.
Two adequate carcinogenicity studies were submitted. One study
conducted on rats showed the presence of rare ocular tumors in male
rats only. The corneal tumors observed in male rats are (1) treatment
related, (2) found at doses that were considered to be adequate and not
excessive for assessing carcinogenicity, (3) there are no concerns for
mutagenicity or genotoxicity, and (4) are supported by structure-
activity relationship (SAR) data for another HPPD inhibitor,
tembotrione. Another study conducted on mice showed lung tumors, which
are not considered treatment related. Because the tumors are found only
in one species and only in males, consistent with the Agency guidelines
for carcinogen risk assessment, the Agency has classified bicyclopyrone
as ``suggestive evidence of cancer'' and has determined that
quantification of bicyclopyrone's carcinogenic potential is not
required. A non-linear approach (i.e., reference dose (RfD)) will
adequately protect for all chronic toxicity, including carcinogenicity
that could result from exposure to bicyclopyrone. Using EPA's non-
linear approach, the 1000X combined uncertainty factor used to
calculate the chronic RfD/chronic population-adjusted dose for the
chronic dietary assessment, generates a dose which is 10,000-fold lower
than the dose at which the ocular tumors were not observed and is thus
protective of their potential formation.
Specific information on the studies received and the nature of the
adverse effects caused by bicyclopyrone as well as the no-observed-
adverse-effect-level (NOAEL) and the lowest-observed-adverse-effect-
level (LOAEL) from the toxicity studies can be found at https://www.regulations.gov in document titled ``Bicyclopyrone: Human Health
Risk Assessment for the Section 3 Registration Action on Cereals (Wheat
and Barley)'' at pp. 29-34 in docket ID number EPA-HQ-OPP-2015-0560.
B. Toxicological Points of Departure/Levels of Concern
Once a pesticide's toxicological profile is determined, EPA
identifies toxicological points of departure (POD) and levels of
concern to use in evaluating the risk posed by human exposure to the
pesticide. For hazards that have a threshold below which there is no
appreciable risk, the toxicological POD is used as the basis for
derivation of reference values for risk assessment. PODs are developed
based on a careful analysis of the doses in each toxicological study to
determine the dose at which the NOAEL and the LOAEL are identified.
Uncertainty/safety factors are used in conjunction with the POD to
calculate a safe exposure level--generally referred to as a population-
adjusted dose (PAD) or a RfD--and a safe margin of exposure (MOE). For
non-threshold risks, the Agency assumes that any amount of exposure
will lead to some degree of risk. Thus, the Agency estimates risk in
terms of the probability of an occurrence of the adverse effect
expected in a lifetime. For more information on the general principles
EPA uses in risk characterization and a complete description of the
risk assessment process, see https://www.epa.gov/pesticides/factsheets/riskassess.htm. A summary of the toxicological endpoints for
bicyclopyrone used for human risk assessment is discussed in Unit III.
B of the final rule published in the Federal Register of April 23, 2015
(80 FR 22648) (FRL-9926-66).
C. Exposure Assessment
1. Dietary exposure from food and feed uses. In evaluating dietary
exposure to bicyclopyrone, EPA considered exposure under the
petitioned-for tolerances as well as all existing bicyclopyrone
tolerances in 40 CFR 180.682. EPA assessed dietary exposures from
bicyclopyrone in food as follows:
i. Acute exposure. Quantitative acute dietary exposure and risk
assessments are performed for a food-use pesticide, if a toxicological
study has indicated the possibility of an effect of concern occurring
as a result of a 1-day or single exposure. Such effects were identified
for bicyclopyrone. In estimating acute dietary exposure, EPA used food
consumption information from the United States Department of
Agriculture (USDA) 2003-2008 Nationwide Continuing Surveys of Food
Intake by Individuals (CSFII). The acute dietary analysis was conducted
for
[[Page 86963]]
bicyclopyrone assuming tolerance level residues, default processing
factors, and 100% crop treatment (PCT) information.
ii. Chronic exposure. In conducting the chronic dietary exposure
assessment EPA used the food consumption data from the USDA 2003-2008
CSFII. The chronic dietary exposure assessment was conducted for
bicyclopyrone assuming average field trial residues for crops, average
empirical processing factors, anticipated residues for livestock
commodities, and PCT estimates for some commodities.
iii. Cancer. Based on the data summarized in Unit III.A., EPA has
determined that a separate cancer exposure assessment does not need to
be conducted.
iv. Anticipated residue and percent crop treated (PCT) information.
Section 408(b)(2)(E) of FFDCA authorizes EPA to use available data and
information on the anticipated residue levels of pesticide residues in
food and the actual levels of pesticide residues that have been
measured in food. If EPA relies on such information, EPA must require
pursuant to FFDCA section 408(f)(1) that data be provided 5 years after
the tolerance is established, modified, or left in effect,
demonstrating that the levels in food are not above the levels
anticipated. For the present action, EPA will issue such data call-ins
as are required by FFDCA section 408(b)(2)(E) and authorized under
FFDCA section 408(f)(1). Data will be required to be submitted no later
than 5 years from the date of issuance of these tolerances.
Section 408(b)(2)(F) of FFDCA states that the Agency may use data
on the actual percent of food treated for assessing chronic dietary
risk only if:
Condition A: The data used are reliable and provide a
valid basis to show what percentage of the food derived from such crop
is likely to contain the pesticide residue.
Condition B: The exposure estimate does not underestimate
exposure for any significant subpopulation group.
Condition C: Data are available on pesticide use and food
consumption in a particular area, the exposure estimate does not
understate exposure for the population in such area.
In addition, the Agency must provide for periodic evaluation of any
estimates used. To provide for the periodic evaluation of the estimate
of PCT as required by FFDCA section 408(b)(2)(F), EPA may require
registrants to submit data on PCT.
The Agency estimated the PCT for existing uses as follows: The
chronic analysis incorporated the following PCT estimates: Field corn,
40% and sweet/popcorn, 35%. The PCT for livestock commodities is based
on the PCT estimate value for the livestock feed item used in the
dietary burden with the highest PCT (field corn, 40%).
In most cases, EPA uses available data from United States
Department of Agriculture/National Agricultural Statistics Service
(USDA/NASS), proprietary market surveys, and the National Pesticide Use
Database for the chemical/crop combination for the most recent 6-7
years. EPA uses an average PCT for chronic dietary risk analysis. The
average PCT figure for each existing use is derived by combining
available public and private market survey data for that use, averaging
across all observations, and rounding to the nearest 5%, except for
those situations in which the average PCT is less than one. In those
cases, 1% is used as the average PCT and 2.5% is used as the maximum
PCT. EPA uses a maximum PCT for acute dietary risk analysis. The
maximum PCT figure is the highest observed maximum value reported
within the recent 6 years of available public and private market survey
data for the existing use and rounded up to the nearest multiple of 5%.
The Agency estimated the PCT for new uses as follows: The chronic
analysis incorporated the following PCT estimates: Barley, 5% and
wheat, 1%.
The Agency believes that the three conditions discussed in Unit
III.C.1.iv. have been met. With respect to Condition A, PCT estimates
are derived from Federal and private market survey data, which are
reliable and have a valid basis. The Agency is reasonably certain that
the percentage of the food treated is not likely to be an
underestimation. As to Conditions B and C, regional consumption
information and consumption information for significant subpopulations
is taken into account through EPA's computer-based model for evaluating
the exposure of significant subpopulations including several regional
groups. Use of this consumption information in EPA's risk assessment
process ensures that EPA's exposure estimate does not understate
exposure for any significant subpopulation group and allows the Agency
to be reasonably certain that no regional population is exposed to
residue levels higher than those estimated by the Agency. Other than
the data available through national food consumption surveys, EPA does
not have available reliable information on the regional consumption of
food to which bicyclopyrone may be applied in a particular area.
2. Dietary exposure from drinking water. The Agency used screening
level water exposure models in the dietary exposure analysis and risk
assessment for bicyclopyrone in drinking water. These simulation models
take into account data on the physical, chemical, and fate/transport
characteristics of bicyclopyrone. Further information regarding EPA
drinking water models used in pesticide exposure assessment can be
found at https://www.epa.gov/oppefed1/models/water/index.htm.
The Surface Water Concentration Calculator (SWCC) computer model
was used to generate surface water Estimated Drinking Water
Concentrations (EDWCs), while the Pesticide Root Zone Model for
Groundwater (PRZM-GW) and the Screening Concentration in Ground Water
(SCI-GROW) models were used to generate groundwater EDWCs. The maximum
acute, chronic, and cancer surface water EDWCs associated with
bicyclopyrone use on wheat and barley were 3.43, 1.02, and 0.46 parts
per billion (ppb), respectively. For groundwater sources of drinking
water, the maximum acute, chronic and cancer EDWCs of bicyclopyrone in
shallow groundwater from PRZM-GW were 4.82, 4.2, and 2.1 ppb,
respectively. EDWCs of 4.82 ppb and 4.2 ppb were used in the acute and
chronic analyses, respectively.
3. From non-dietary exposure. The term ``residential exposure'' is
used in this document to refer to non-occupational, non-dietary
exposure (e.g., for lawn and garden pest control, indoor pest control,
termiticides, and flea and tick control on pets). Bicyclopyrone is not
registered for any specific use patterns that would result in
residential exposure.
4. Cumulative effects from substances with a common mechanism of
toxicity. Section 408(b)(2)(D)(v) of FFDCA requires that, when
considering whether to establish, modify, or revoke a tolerance, the
Agency consider ``available information'' concerning the cumulative
effects of a particular pesticide's residues and ``other substances
that have a common mechanism of toxicity.''
There are marked differences among species in the ocular toxicity
associated with bicyclopyrone's mechanism of toxicity, the inhibition
of HPPD. Ocular effects following treatment with HPPD inhibitor
herbicides are seen in the rat but not in the mouse. Monkeys also seem
to be recalcitrant to the ocular toxicity induced by HPPD inhibition.
One explanation for this species-specific response in ocular opacity
may be related to species differences in the clearance of tyrosine. A
metabolic pathway exists to remove tyrosine from the blood that
involves the liver enzyme tyrosine aminotransferase (TAT). In
[[Page 86964]]
contrast to rats where ocular toxicity is observed following exposure
to HPPD-inhibiting herbicides, mice and humans are unlikely to achieve
the levels of plasma tyrosine necessary to produce ocular opacities
because the activity of TAT in these species is much greater compared
to rats.
HPPD inhibitors (e.g., nitisinone) are used as an effective
therapeutic agent to treat patients suffering from rare genetic
diseases of tyrosine catabolism. Treatment starts in childhood but is
often sustained throughout patient's lifetime. The human experience
indicates that a therapeutic dose (1 mg/kg/day dose) of nitisinone has
an excellent safety record in infants, children, and adults and that
serious adverse health outcomes have not been observed in a population
followed for approximately a decade. Rarely, ocular effects are seen in
patients with high plasma tyrosine levels; however, these effects are
transient and can be readily reversed upon adherence to a restricted
protein diet. This observation indicates that an HPPD inhibitor in and
of itself cannot easily overwhelm the tyrosine-clearance mechanism in
humans.
Therefore, exposures to environmental residues of HPPD-inhibiting
herbicides are unlikely to result in the high blood levels of tyrosine
and ocular toxicity in humans due to an efficient metabolic process to
handle excess tyrosine. The EPA continues to study the complex
relationships between elevated tyrosine levels and biological effects
in various species. In the future, assessments of HPPD-inhibiting
herbicides may consider more appropriate models and cross species
extrapolation methods. Therefore, EPA has not conducted cumulative risk
assessment with other HPPD inhibitors.
D. Safety Factor for Infants and Children
1. In general. Section 408(b)(2)(C) of FFDCA provides that EPA
shall apply an additional tenfold (10X) margin of safety for infants
and children in the case of threshold effects to account for prenatal
and postnatal toxicity and the completeness of the database on toxicity
and exposure unless EPA determines based on reliable data that a
different margin of safety will be safe for infants and children. This
additional margin of safety is commonly referred to as the Food Quality
Protection Act Safety Factor (FQPA SF). In applying this provision, EPA
either retains the default value of 10X, or uses a different additional
safety factor when reliable data available to EPA support the choice of
a different factor.
2. The FQPA SF is retained at 10X for all exposure scenarios based
on use of a LOAEL for the points of departure. The toxicology database
for bicyclopyrone is adequate for characterizing toxicity and
quantification of risk for food and non-food uses; however, a LOAEL
from the New Zealand white rabbit developmental and chronic/
carcinogenicity rat toxicity studies has been used as the POD for
several scenarios.
There is no evidence of neurotoxicity in either of the
neurotoxicity screening batteries, but there are effects in the chronic
dog study. The level of concern is low, however, since the study and
POD chosen for the chronic dietary exposure scenario is protective of
these effects. There is evidence of increased quantitative fetal
susceptibility following in utero exposure in both rats and rabbits;
however, these effects are well characterized and the selected
endpoints are protective of the observed fetal effects. Lastly, there
are no residual uncertainties in the exposure database.
E. Aggregate Risks and Determination of Safety
EPA determines whether acute and chronic dietary pesticide
exposures are safe by comparing aggregate exposure estimates to the
acute PAD (aPAD) and chronic PAD (cPAD). For linear cancer risks, EPA
calculates the lifetime probability of acquiring cancer given the
estimated aggregate exposure. Short-, intermediate-, and chronic-term
risks are evaluated by comparing the estimated aggregate food, water,
and residential exposure to the appropriate PODs to ensure that an
adequate MOE exists.
1. Acute risk. Using the exposure assumptions discussed in this
unit for acute exposure, the acute dietary exposure from food and water
to bicyclopyrone will occupy 4.6% of the aPAD for females 13-49 years
old, the population group receiving the greatest exposure.
2. Chronic risk. Using the exposure assumptions described in this
unit for chronic exposure, EPA has concluded that chronic exposure to
bicyclopyrone from food and water will utilize 90% of the cPAD for
children <1 years old the population group receiving the greatest
exposure. There are no residential uses for bicyclopyrone.
3. Short-term risk. A short-term adverse effect was identified;
however, bicyclopyrone is not registered for any use patterns that
would result in short-term residential exposure. Short-term risk is
assessed based on short-term residential exposure plus chronic dietary
exposure. Because there is no short-term residential exposure and
chronic dietary exposure has already been assessed under the
appropriately protective cPAD (which is at least as protective as the
POD used to assess short-term risk), no further assessment of short-
term risk is necessary, and EPA relies on the chronic dietary risk
assessment for evaluating short-term risk for bicyclopyrone.
4. Intermediate-term risk. An intermediate-term adverse effect was
identified; however, bicyclopyrone is not registered for any use
patterns that would result in intermediate-term residential exposure.
Intermediate-term risk is assessed based on intermediate-term
residential exposure plus chronic dietary exposure. Because there is no
intermediate-term residential exposure and chronic dietary exposure has
already been assessed under the appropriately protective cPAD (which is
at least as protective as the POD used to assess intermediate-term
risk), no further assessment of intermediate-term risk is necessary,
and EPA relies on the chronic dietary risk assessment for evaluating
intermediate-term risk for bicyclopyrone.
5. Aggregate cancer risk for U.S. population. Because the Agency
has determined that the chronic RfD will be protective of any potential
cancer risk and there is not a chronic risks do not exceed the Agency's
level of concern, EPA concludes that there is not a concern for cancer
risk from exposure to bicyclopyrone.
6. Determination of safety. Based on these risk assessments, EPA
concludes that there is a reasonable certainty that no harm will result
to the general population, or to infants and children from aggregate
exposure to bicyclopyrone residues.
IV. Other Considerations
A. Analytical Enforcement Methodology
Adequate enforcement methodology liquid chromatography-mass
spectroscopy/mass spectroscopy (LC-MS/MS) methods for tolerance
enforcement have been developed and independently validated. For all
matrices and analytes, the level of quantification (LOQ), defined as
the lowest spiking level where acceptable precision and accuracy data
were obtained, was determined to be 0.01 ppm for each of the common
moieties, SYN503780 and CSCD686480, for a combined LOQ of 0.02 ppm is
available to enforce the tolerance expression.
The method may be requested from: Chief, Analytical Chemistry
Branch, Environmental Science Center, 701
[[Page 86965]]
Mapes Rd., Ft. Meade, MD 20755-5350; telephone number: (410) 305-2905;
email address: residuemethods@epa.gov.
B. International Residue Limits
In making its tolerance decisions, EPA seeks to harmonize U.S.
tolerances with international standards whenever possible, consistent
with U.S. food safety standards and agricultural practices. EPA
considers the international maximum residue limits (MRLs) established
by the Codex Alimentarius Commission (Codex), as required by FFDCA
section 408(b)(4). The Codex Alimentarius is a joint United Nations
Food and Agriculture Organization/World Health Organization food
standards program, and it is recognized as an international food safety
standards-setting organization in trade agreements to which the United
States is a party. EPA may establish a tolerance that is different from
a Codex MRL; however, FFDCA section 408(b)(4) requires that EPA explain
the reasons for departing from the Codex level. The Codex has not
established a MRL for bicyclopyrone.
C. Revisions to Petitioned-For Tolerances
The requested tolerance levels for some wheat and barley raw
agricultural commodities (RAC) differ slightly from those being set by
the EPA. Although both the petitioner and EPA have used the
Organization for Economic Cooperation and Development (OECD)
calculation procedures to determine tolerance levels, EPA determined
that some of the field residue trials were not independent, thus
resulting in different inputs. Using the highest average RAC residues
and average processing factors, EPA calculated tolerance levels for
processed commodities that were generally lower than those requested
and determined that the requested tolerances for residues in/on wheat
and barley germ are not necessary as the expected residue levels are
covered by the RAC tolerance levels.
Consistent with 40 CFR 180.6, EPA is amending existing livestock
commodity tolerances as necessary. As a result of increased dietary
burdens resulting from the use on wheat and barley commodities, the
existing tolerances of 1.5 ppm for residues in/on the meat byproducts
of cattle, goats, horses, and sheep are increased to 2.0 ppm; and the
existing tolerance of 0.15 ppm for residues in/on for hog meat
byproducts is increased to 0.40 ppm.
In addition, EPA changed the commodity terminology for aspirated
grain fractions to grain, aspirated fractions in order to conform to
terms used in the Agency's Food and Feed Commodity Vocabulary and
amended the tolerance value for barley, hay from 0.3 ppm to 0.30 ppm to
conform with the Agency policy to carry tolerance levels out two
significant figures.
V. Conclusion
Therefore, tolerances are established for residues of the herbicide
bicyclopyrone in or on barley, bran at 0.15 ppm; barley, grain, at 0.07
ppm; barley, hay at 0.30 ppm; barley, straw at 0.40 ppm; cattle, meat
byproducts at 2.0 ppm; goat, meat byproducts at 2.0 ppm; grain,
aspirated fractions at 0.30 ppm; hog, meat byproducts at 0.40 ppm;
horse, meat byproducts at 2.0 ppm; sheep, meat byproducts at 2.0 ppm;
wheat, bran at 0.07 ppm; wheat, forage at 0.40 ppm; wheat, grain, at
0.04 ppm; wheat, hay at 0.80 ppm; and wheat, straw at 0.50 ppm.
VI. Statutory and Executive Order Reviews
This action establishes tolerances under FFDCA section 408(d) in
response to a petition submitted to the Agency. The Office of
Management and Budget (OMB) has exempted these types of actions from
review under Executive Order 12866, entitled ``Regulatory Planning and
Review'' (58 FR 51735, October 4, 1993). Because this action has been
exempted from review under Executive Order 12866, this action is not
subject to Executive Order 13211, entitled ``Actions Concerning
Regulations That Significantly Affect Energy Supply, Distribution, or
Use'' (66 FR 28355, May 22, 2001) or Executive Order 13045, entitled
``Protection of Children from Environmental Health Risks and Safety
Risks'' (62 FR 19885, April 23, 1997). This action does not contain any
information collections subject to OMB approval under the Paperwork
Reduction Act (PRA) (44 U.S.C. 3501 et seq.), nor does it require any
special considerations under Executive Order 12898, entitled ``Federal
Actions to Address Environmental Justice in Minority Populations and
Low-Income Populations'' (59 FR 7629, February 16, 1994).
Since tolerances and exemptions that are established on the basis
of a petition under FFDCA section 408(d), such as the tolerance in this
final rule, do not require the issuance of a proposed rule, the
requirements of the Regulatory Flexibility Act (RFA) (5 U.S.C. 601 et
seq.), do not apply.
This action directly regulates growers, food processors, food
handlers, and food retailers, not States or tribes, nor does this
action alter the relationships or distribution of power and
responsibilities established by Congress in the preemption provisions
of FFDCA section 408(n)(4). As such, the Agency has determined that
this action will not have a substantial direct effect on States or
tribal governments, on the relationship between the national government
and the States or tribal governments, or on the distribution of power
and responsibilities among the various levels of government or between
the Federal Government and Indian tribes. Thus, the Agency has
determined that Executive Order 13132, entitled ``Federalism'' (64 FR
43255, August 10, 1999) and Executive Order 13175, entitled
``Consultation and Coordination with Indian Tribal Governments'' (65 FR
67249, November 9, 2000) do not apply to this action. In addition, this
action does not impose any enforceable duty or contain any unfunded
mandate as described under Title II of the Unfunded Mandates Reform Act
(UMRA) (2 U.S.C. 1501 et seq.).
This action does not involve any technical standards that would
require Agency consideration of voluntary consensus standards pursuant
to section 12(d) of the National Technology Transfer and Advancement
Act (NTTAA) (15 U.S.C. 272 note).
VII. Congressional Review Act
Pursuant to the Congressional Review Act (5 U.S.C. 801 et seq.),
EPA will submit a report containing this rule and other required
information to the U.S. Senate, the U.S. House of Representatives, and
the Comptroller General of the United States prior to publication of
the rule in the Federal Register. This action is not a ``major rule''
as defined by 5 U.S.C. 804(2).
List of Subjects in 40 CFR Part 180
Environmental protection, Administrative practice and procedure,
Agricultural commodities, Pesticides and pests, Reporting and
recordkeeping requirements.
Dated: November 3, 2016.
Michael Goodis,
Acting Director, Registration Division, Office of Pesticide Programs.
Therefore, 40 CFR chapter I is amended as follows:
PART 180--[AMENDED]
0
1. The authority citation for part 180 continues to read as follows:
Authority: 21 U.S.C. 321(q), 346a and 371.
0
2. In Sec. 180.682, revise the table in paragraph (a)(1) to read as
follows:
[[Page 86966]]
Sec. 180.682 Bicyclopyrone; tolerances for residues.
(a) * * *
(1) * * *
------------------------------------------------------------------------
Parts per
Commodity million
------------------------------------------------------------------------
Barley, bran............................................ 0.15
Barley, grain........................................... 0.07
Barley, hay............................................. 0.30
Barley, straw........................................... 0.40
Cattle, meat byproducts................................. 2.0
Corn, field, forage..................................... 0.30
Corn, field, grain...................................... 0.02
Corn, field, stover..................................... 0.40
Corn, pop, grain........................................ 0.02
Corn, pop, stover....................................... 0.40
Corn, sweet, forage..................................... 0.40
Corn, sweet, kernel plus cob with husks removed......... 0.03
Corn, sweet, stover..................................... 0.70
Goat, meat byproducts................................... 2.0
Grain, aspirated fractions.............................. 0.30
Hog, meat byproducts.................................... 0.40
Horse, meat byproducts.................................. 2.0
Sheep, meat byproducts.................................. 2.0
Sugarcane, cane \1\..................................... 0.02
Wheat, bran............................................. 0.07
Wheat, forage........................................... 0.40
Wheat, grain............................................ 0.04
Wheat, hay.............................................. 0.80
Wheat, straw............................................ 0.50
------------------------------------------------------------------------
\1\ There are no U.S. Registration on Sugarcane as of March 13, 2015.
* * * * *
[FR Doc. 2016-29005 Filed 12-1-16; 8:45 am]
BILLING CODE 6560-50-P